03:43 PM EDT, 03/20/2024 (MT Newswires) -- Health care stocks fell late Wednesday afternoon with the NYSE Health Care Index shedding 0.4% and the Health Care Select Sector SPDR Fund (XLV) down 0.2%.

The iShares Biotechnology ETF (IBB) rose 0.2%.

In corporate news, Acelyrin ( SLRN ) shares gained 3.8% after the company said a trial of lonigutamab for thyroid eye disease showed rapid improvements in proptosis, or bulging eyes, and clinical activity score within three weeks after the first dose.